These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17707550)

  • 1. 2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.
    Szénási G; Vegh M; Szabo G; Kertesz S; Kapus G; Albert M; Greff Z; Ling I; Barkoczy J; Simig G; Spedding M; Harsing LG
    Neurochem Int; 2008 Jan; 52(1-2):166-83. PubMed ID: 17707550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on new AMPA antagonists of 2,3-benzodiazepine type.
    Sólyom S
    Pharmazie; 2001 Oct; 56 Suppl 1():S62-6. PubMed ID: 11686094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
    Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
    Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
    Rogawski MA; Donevan SD
    Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.
    Ritz M; Micale N; Grasso S; Niu L
    Biochemistry; 2008 Jan; 47(3):1061-9. PubMed ID: 18161947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
    Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
    Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
    Elger B; Huth A; Neuhaus R; Ottow E; Schneider H; Seilheimer B; Turski L
    J Med Chem; 2005 Jul; 48(14):4618-27. PubMed ID: 15999999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental characteristics of AMPA receptors in chick lumbar motoneurons.
    Ni X; Sullivan GJ; Martin-Caraballo M
    Dev Neurobiol; 2007 Sep; 67(11):1419-32. PubMed ID: 17497695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mechanisms of action of the adamantane derivative IEM-1460 at human AMPA-type glutamate receptors.
    Schlesinger F; Tammena D; Krampfl K; Bufler J
    Br J Pharmacol; 2005 Jul; 145(5):656-63. PubMed ID: 15834439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective KDI domain of gamma 1-laminin is a universal and potent inhibitor of ionotropic glutamate receptors.
    Möykkynen T; Liebkind R; Sjöberg J; Korpi ER; Liesi P
    J Neurosci Res; 2005 Sep; 81(6):797-804. PubMed ID: 16044429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
    Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
    Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus.
    Schiapparelli L; Simón AM; Del Río J; Frechilla D
    Neuropharmacology; 2006 Jun; 50(7):897-907. PubMed ID: 16620883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor.
    Macchiarulo A; De Luca L; Costantino G; Barreca ML; Gitto R; Pellicciari R; Chimirri A
    J Med Chem; 2004 Mar; 47(7):1860-3. PubMed ID: 15027880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling.
    Weiczner R; Krisztin-Péva B; Mihály A
    Epilepsy Res; 2008 Jan; 78(1):22-32. PubMed ID: 18036781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators.
    Kessler M; Arai AC
    Brain Res; 2006 Mar; 1076(1):25-41. PubMed ID: 16256076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.